Searching journal content for thyroid nodule (as phrase) in full text.

Displaying results 1-10 of 79
For checked items
  1. ...thyroid nodule management effects? Report from the French 517 Thyroid Cancer Committee. Thyroid 14 1056-1060. 518 Letouze E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, Janin M, Menara M, 519 Nguyen AT, Benit P, et al. 2013 SDH mutations establish a hypermethylator phenotype in 520 ~~~
  2. ...thyroid nodule in a MEN type 1 patient. Journal of Clinical Ultrasound 42 212–214. (doi:10.1002/jcu.22090) Lemos MC & Thakker RV 2008 Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Human Mutation 29 22–32. (do ~~~
  3. ...thyroid nodule or a multinodular goiter was confirmed on ultrasound. Diabetes was considered as being present when a diagnosis had been made in the medical history of the patient and/or a recorded glucose value of ≥200 mg/dL was found at 120 min during a standard oral glucose tolerance test (OGTT). ~~~
  4. ...thyroid nodule clinical pathway. Histologies of nodules with follicular variant papillary thyroid carcinoma or NIFTP diagnoses were reviewed, with reviewers blinded to molecular results. ThyroSeq v2 performance was calculated in nodules with histological confirmation. We identified a mutation in 24% ~~~
  5. ...thyroid nodule and thyroid cancer management that have undergone major changes in recent years and present how different recent guidelines address these topics. These guidelines are those of the American Thyroid Association (ATA) published in 2016 (Haugen et al. 2016), the National Comprehensive Can ~~~
  6. ...thyroid nodule and cancer in a series of 338 patients is 5%. Out of these 11 cases, 6 were follicular adenomas (hyperfunctioning in 2), 3 were papillary thyroid carcinomas (with a case with follicular variant sub-type) and 2 were follicular thyroid carcinomas (Stratakis et al. 1996, 1997, 2001). An ~~~
  7. ...thyroid nodule positive for papillary thyroid carcinoma (PTC). Histopathological review of F1.9 patient confirmed the PTC besides C-cell hyperplasia. In addition, patients F1.8 and F1.10 also demonstrated small PTCs on surgical specimens (Table 2). In 7/12 relatives carrying the M918V mutation with ~~~
  8. ...thyroid nodule of less than 1 cm in size (Moon et  al. 2012). However, not all studies are consistent. Sohn et al. (2014) demonstrated the association between higher TSH and risk of malignancy in tumours over 1 cm, but not in papillary microcarcinomas. Similarly, an Italian study showed that TSH was ~~~
  9. ...thyroid nodule ~~~
  10. ...thyroid nodule with or without cervical lymphadenopathy. In rare cases, MTC can cause Cushing’s syndrome through ectopic production of ACTH or CRH. Molecular pathophysiology MEN2A is caused by gain­of­function mutation in the RET protooncogene. RET encodes a transmembrane receptor tyrosine kinase wh ~~~
For checked items